Form 4: Carlyle Group Sells Additional Shares of QuidelOrtho Corp (QDEL) Under 10b5-1 Trading Plan

The Carlyle Group continues to reduce its stake in QuidelOrtho Corp, selling shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• The Carlyle Group, along with affiliated entities, has sold shares of QuidelOrtho Corp (QDEL) on June 25 and June 26, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• On June 25, 2024, 41,299 shares were sold at a weighted average price of $32.893, with individual prices ranging from $32.6905 to $32.9999.
• An additional 26,173 shares were sold on June 25, 2024, at a weighted average price of $33.1981, with prices ranging from $33.00 to $33.7555.
• On June 26, 2024, 17,568 shares were sold at a weighted average price of $32.8964, with prices ranging from $32.48 to $32.9998.
• Finally, 63,914 shares were sold on June 26, 2024, at a weighted average price of $33.2731, with prices ranging from $33.00 to $33.7741.
• Following these transactions, the Carlyle Group and affiliated entities still indirectly beneficially own 11,617,068 shares of QuidelOrtho Corp.
• The various entities involved, including Carlyle Partners VI Cayman Holdings, L.P., TC Group Cayman Investment Holdings, L.P., and others, have disclaimed beneficial ownership of the securities.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting share sales. It doesn't convey any explicit positive or negative sentiment about the company's performance or prospects. The sales are part of a pre-arranged plan, so they are not necessarily indicative of a change in outlook.

Risks

• Continued sales by Carlyle Group could exert downward pressure on QDEL's stock price.

Industry Context

Private equity firms like Carlyle often reduce their holdings in portfolio companies over time to realize returns for their investors. This is a common practice and doesn't necessarily reflect a negative outlook on the company's future.

Stakeholder Impact

• The share sales could potentially exert downward pressure on the stock price, impacting shareholders.

Key Dates